➢ Contact Our Law Firm to Start Your Claim Today

Patients who used Ozempic, Mounjaro, Wegovy, or other diabetes and weight loss drugs and have been diagnosed with gastroparesis, stomach paralysis (“frozen stomach”), or other serious gastrointestinal conditions may qualify to file a lawsuit and receive compensation for their injuries.

To start your claim today, contact the law firm of Hissey Mulderig & Friend by calling our office toll-free at 1-866-806-8117, or by filling our our free claims submission form on the right side of this page.

————————————

➢ Ozempic Linked to Gastroparesis & Other Stomach Problems

Ozempic (semaglutide) was originally developed and approved by the FDA as a treatment for type 2 diabetes. After the drug was released in 2017, doctors realized that Ozempic could also be effective at treating patients with obesity. In 2021, the FDA approved the drug Wegovy, which also contains semaglutide, for long-term weight control.

Ozempic and Wegovy became so widely-prescribed for weight management that the FDA officially added these medications to its drug shortages list in 2023. However, around this time, media outlets also began reporting on serious stomach problems among patients who were taking these drugs for weight loss or diabetes treatment.

Some patients who have used Ozempic or Wegovy have developed gastroparesis, a chronic condition which causes a weakening of the nerves and muscles in the stomach. Because these nerves and muscles are weaker in patients with gastroparesis, patients with this condition have trouble transferring food to the small intestines, causing nausea, diarrhea, or other side effects.

➢ Ozempic Lawsuits Filed Over Gastroparesis & Other Side Effects

Following reports of gastroparesis and other serious stomach problems linked to Ozempic and Wegovy, the first lawsuit about the side effects of these medications was filed in August 2023. The lawsuit was filed by a women who used Ozempic and another drug, Mounjaro, to manage her diabetes symptoms and was later diagnosed with gastroparesis and other serious gastrointestinal problems.

Since the first Ozempic lawsuit was filed last year, dozens of additional lawsuits have been filed by patients who were diagnosed with gastroparesis or other gastrointestinal conditions after taking Ozempic or other weight loss and diabetes medications. 

The 55 lawsuits filed so far have alleged that Novo Nordisk, Eli Lilly, and other pharmaceutical companies failed to properly warn patients who used Ozempic, Wegovy, and other medications in their class about the risk of serious gastrointestinal side effects that they could face from taking these drugs to treat diabetes or for weight loss.

In February 2024, these 55 pending Ozempic and Mounjaro lawsuits against Novo Nordisk and Eli Lilly were centralized in a multidistrict litigation, or MDL, in Pennsylvania. By combining these cases in an MDL, the judge in the case will be able to issue ruling that apply to all the lawsuits, making it easier for patients to receive damages or a settlement in their claim.

Lawyers involved in the Ozempic and Mounjaro MDL say that they expect that as many as 10,000 lawsuits involving these weight loss and diabetes drugs will eventually be filed by patients who developed gastroparesis or other gastrointestinal conditions.

➢ Other Stomach Problems Caused by Weight Loss Drugs

In addition to Ozempic and Wegovy, the FDA has also received reports of serious stomach conditions linked to other drugs used for weight loss and diabetes treatment. 

These medications – along with Ozempic and Wegovy – are part of a class of medications known as GLP-1 receptor agonists.

Other brand name and generic medications that are part of this class of drugs include:

  • Mounjaro (tirzepatide)
  • Rybelsus (semiglutide)
  • Saxenda (liraglutide)
  • Trulicity (dulaglutide)

Besides gastroparesis, Ozempic, Wegovy, and the above medications have also been linked to other serious stomach conditions, including:

  • Bowel obstructions
  • Ileus (inability of the intestine to push food or waste out of the body)
  • Intestinal blockages
  • Stomach paralysis (“frozen stomach”)

➢ Start Your Claim Today

Did you or a loved one used Ozempic, Wegovy, semiglutide, or other weight loss and diabetes medications that have been linked to gastroparesis or other serious stomach conditions? 

If so, you may be eligible to file a lawsuit and receive compensation from the manufacturers of these drugs.

To start the process of filing your claim today, contact the lawyers at Hissey Mulderig & Friend by filling out our free claims submission form located at the top of this page. You can also reach us by calling our office toll-free at 1-866-806-8117.